美宝湿润烧伤膏治疗特应性皮炎的疗效观察

目的：探讨美宝湿润烧伤膏治疗轻中度特应性皮炎（AD）的临床疗效。 方法：治疗慢性AD患者90例，病情为轻、中度。随机分为治疗组和对照组，每组45例。治疗组：外用美宝湿润烧伤膏(MEBO)治疗，每日2次；对照组：外用丁酸氢化可的松乳膏，每日2次。连用4周。 结果：治疗组痊愈率22.2％，有效率为66.7％，对照组痊愈率26.7％，有效率为73.3％；治疗组与对照组疗效无差异性(P>0.05)。 结论：美宝湿润烧伤膏(MEBO)能明显改善了AD患者皮损的严重程度，对轻、中度AD患者的治疗中疗效等同于中强效激素，可有效控制其临床症状，并发症少，适合中、长期使用，具有很好的临床应用价值。

The study on Mebo moist burn cream for the treatment of atopic dermatitis

Objective: To evaluate the MEBO moist burn cream for the treatment of mild to moderate atopic dermatitis( AD). Methods: Ninety patients with mild and moderate chronic AD were randomly divided into study group and control group. Patients of study group were treated with MEBO moist burn cream two times per day, the patients in control group were treated with Hydrocortisone Butyrate Cream two times per day. All the patients were treated for 4 weeks. Results: During the observation of 4 weeks, the cure rate and effective rate of the study group were 22.2% and 66.7%, respectively. The cure rate and effective rate of the control group were 26.7% and 73.3%, respectively. There was no significant difference between the study group and control group (p>0.05). Conclusion: The MEBO can alleviate the damage of the skin of patients with AD. The effect of treatment was similar as the prednisone. MEBO had less side effects and could be used for longer time, with great value in clinical application